Comparison of the Effects of ILO and LLO in Helping Listeria Adhere,Invade Cell and Intracellularly Multiply

LIU Si-jing, LIU Ting, ZHOU Yu-zhen.et al

Abstract

To study the primary function of ivanolysin O (ILO) and Listeriolysin O (LLO) and compare the effects of these two hemolysins in helping bacteria adhere,invade cell and intracellularly multiply. MethodsThe targeting plasmids carrying the upstream and downstream sequences of i-hly and lacZ gene sequence or hly gene sequence were constructed. Then two recombinant strains,the ILO deletion strain LIΔi-hly∷lacZ and LLO compensative expressing strain LIΔi-hly∷hly,were constructed by plasmid targeting recombinant technique. The adhesive and invasive ability of LIΔi-hly∷hly,LI and LIΔi-hly∷lacZ were evaluated in HepG2 cells,and their intracellular multiplication abilities were evaluated in RAW264.7 macrophages. ResultsGenome sequences of the recombinant strains were as expected. The adhesive rate of LIΔi-hly∷hly,LI and LIΔi-hly∷lacZ were (3.43±0.82)%,(3.43±1.59)% and (3.41±1.12)% respectively,and the invasive rate were (1.74±0.46)%,(1.22±0.75)% and (1.39±0.46)% respectively. Difference in adhesive and invasive rates showed no significance. Among three strains,LIΔi-hly∷lacZ showed the lowest intracellular proliferation rate,and LIΔi-hly∷hly possessed the highest intracellular proliferation rate in RAW264.7 macrophages. ConclusionThe intracellular multiplication ability of LI is related to ILO. Deletion of ILO induces a distinct decrease in intracellular multiplication for LI. Compared with ILO,LLO shows a stronger ability in helping the bacteria escape from the phagosome into the host cell cytosol.

 

Keywords: Listeria ivanoviiListeria monocytogenes, Listeriolysin,  OIvanolysin, OIntracellular multiplication 

 

Full Text:

PDF


References


WALLECHA A, CARROLL KD, MACIAG PC, et al. Multiple effector mechanisms induced by recombinant Listeria mcmocy/ogine, anticancer immunotherapeutics. Adv Appl Microbiol, 2009, 66: 1-27 [ 2018-07-22]. https;//doi. org/10. 1016/S0065-2164(08)00801-0.

LEDT, DUBENKSY TW, BROCKSTEDT DG. Clinical development of Listeria monocytogenes-based immunotherapies. Semin Oncol,2012,39(3):311-322.

FABRIZIA S, CRISTEL A, PASCALE C. Cell biology and immunology of Listeria monocytogenes infections; novel insights. Immunol Rev,2011,240( 1): 160-184.

LIU D. Molecular approaches to the identification of pathogenic and nonpathogenic Listeriae. Microbiol Insights, 2013,6(6):59-69.

LIN Q. ZHOU M, XU Z, et al. Construction of two Listeria ivanovii a ttenuated strains expressing Mycobacterium tuberculosis antigens for ТВ vaccine purposes. J Biotechnol, 2015, 196-197:20-26[ 2018-07-22]. https;//www. sciencedirect. com/science/article/pii/SO 1681 65615000176? via%3Dihub. doi; 10. 1016/j. jbiotec. 2015. 01. 008.

ZHOU M, JIANG M, REN C, et al. Listeria ivanovii infection in mice; restricted to the liver and lung with limited replication in the spleen. Front Microbiol,2016,7;790[2018- 07-22 ]. https ://www. frontiersin. org/articles/10. 3389/ fmicb. 2016. 00790/full, doi: 10. 3389/fmicb. 2016. 00790.

FABRIZIA S, FREDERIC B. ANNA S, et al. Listeria monocytogenes transiently alters mitochondrial dynamics during infection. Proc Natl Acad Sci U S A,2011, 108(9); 3612-3617.

FREHELC, LETY M, AUTRET N, ET AL. Capacity of ivanolysin O to replace listeriolysin C) in phagosomal escape and in vivo survival of Listeria monocytogenes. Microbiology,2003,149(3):611-620.

HERNANDEZFLORES KG, VIVANCOCID H. Biological effects of listeriolysin Os implications for vaccination. Biomed Res Int, 2015, 2015:36074l[ 2018-07-22]. https://www. hindawi. com/journals/bmri/2015/360741/. doi: 10. 1155/ 2015/360741.


Refbacks

  • There are currently no refbacks.